UBS Lux Equity Fund Biotech USD vs TIN Ny Teknik

UBS Lux Equity Fund Biotech USD vs TIN Ny Teknik

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. TIN Ny Teknik

  • Security

    TIN Ny Teknik A

  • Fee

    1.50%

  • ISIN

    SE0012193019

  • Holdings

    10

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with TIN Ny Teknik, we have 10 holdings where Surgical Science is the largest holding (7.39), followed by Novo Nordisk (5.98) and ChemoMetec (5.92).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and TIN Ny Teknik.

UBS Lux Equity Fund Biotech USD TIN Ny Teknik
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Surgical Science Sweden AB
Sweden
7.39 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. Novo Nordisk B
Denmark
5.98 %
3. Moderna Inc
9.21 %
3. ChemoMetec
Denmark
5.92 %
4. Alnylam Pharmaceuticals Inc
6.54 %
4. Paradox Interactive AB
Sweden
5.85 %
5. AbbVie Inc
USA
5.52 %
5. Qt Group Plc
Finland
5.12 %
6. Gilead Sciences Inc
USA
4.66 %
6. Epidemic Sound Holdings AB
Sweden
5.11 %
7. Amgen Inc
4.32 %
7. BioGaia B
Sweden
5.06 %
8. BioNTech SE
4.13 %
8. Fortnox AB
Sweden
5.02 %
9. Karuna Therapeutics Inc
3.75 %
9. Evolution Gaming Group AB
Sweden
4.6 %
10. Royalty Pharma Plc
3.28 %
10. Sectra B
Sweden
4.45 %

The list of fund holdings was last updated on April 17, 2025.